This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
24/7 Access
Digital & In-Person
Menu

Tom Atherton, Ph.D.
Senior Scientist at GlaxoSmithKline
Speaker

Profile

Tom received a PhD in analytical chemistry from the University of Lincoln (UK), and joined GSK in 2016. He is part of the mass spectrometry characterisation group supporting both small molecule and oligonucleotide development projects. For the past 3 years he has been working on oligonucleotide projects supporting structure elucidation, confirmation and ID testing.

Agenda Sessions

  • Introduction into Identity Testing Strategies and Development of a Sequence Sensitive Method Using In-source Fragmentation on A Low-resolution LC-MS Instrument

    On Demand - Premium Only
    View Session

At this event

Prev
Next
Mimoun Ayoub, PhD
Director and Head of North American and Emerging Markets
CordenPharma International

See Tom at TIDES: Oligonucleotide & Peptide Therapeutics Content Hub